Capadiso, Rhian .
HRN: 28-13-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/21/2025
11/28/2025
IV
325mg
Q6h
PCAP
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines